Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilde Bjørndal

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Medical Screening|January 16, 2007
Number and characteristics of breast cancer cases diagnosed in four periods in the screening interval of a biennial population-based screening programmeSolveig Hofvind, Nils Bjurstam, Ragnhild Sørum, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 11, 2019
Pathway times in the mammography programme before and after introduction of the breast cancer care pathwayKaitlyn M Tsuruda, Sameer Bhargava, Lars A Akslen, et al.
European Radiology|June 13, 2019
Screening outcome for consecutive examinations with digital breast tomosynthesis versus standard digital mammography in a population-based screening programTone Hovda, Siri H B Brandal, Sofie Sebuødegård, et al.
Radiology|October 26, 2005
Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening programSolveig Hofvind, Per Skaane, Bedrich Vitak, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|May 18, 2012
Digital breast tomosynthesis (DBT): initial experience in a clinical settingPer Skaane, Randi Gullien, Hilde Bjørndal, et al.
Radiology|December 11, 2019
Interval and Consecutive Round Breast Cancer after Digital Breast Tomosynthesis and Synthetic 2D Mammography versus Standard 2D Digital Mammography in BreastScreen NorwayTone Hovda, Åsne S Holen, Kristina Lång, et al.
Cancers|February 13, 2026
MRI for Predicting Response and 10-Year Outcome of Neoadjuvant Chemotherapy with or Without Additional Bevacizumab Treatment in HER2-Negative Breast CancerSiri Helene Bertelsen Brandal, Torgeir Mo, Anne Fangberget, et al.
Radiology|March 2, 2018
Digital Breast Tomosynthesis and Synthetic 2D Mammography versus Digital Mammography: Evaluation in a Population-based Screening ProgramSolveig Hofvind, Tone Hovda, Åsne S Holen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Medical Screening|January 16, 2007
Number and characteristics of breast cancer cases diagnosed in four periods in the screening interval of a biennial population-based screening programmeSolveig Hofvind, Nils Bjurstam, Ragnhild Sørum, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 11, 2019
Pathway times in the mammography programme before and after introduction of the breast cancer care pathwayKaitlyn M Tsuruda, Sameer Bhargava, Lars A Akslen, et al.
European Radiology|June 13, 2019
Screening outcome for consecutive examinations with digital breast tomosynthesis versus standard digital mammography in a population-based screening programTone Hovda, Siri H B Brandal, Sofie Sebuødegård, et al.
Radiology|October 26, 2005
Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening programSolveig Hofvind, Per Skaane, Bedrich Vitak, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|May 18, 2012
Digital breast tomosynthesis (DBT): initial experience in a clinical settingPer Skaane, Randi Gullien, Hilde Bjørndal, et al.
Radiology|December 11, 2019
Interval and Consecutive Round Breast Cancer after Digital Breast Tomosynthesis and Synthetic 2D Mammography versus Standard 2D Digital Mammography in BreastScreen NorwayTone Hovda, Åsne S Holen, Kristina Lång, et al.
Cancers|February 13, 2026
MRI for Predicting Response and 10-Year Outcome of Neoadjuvant Chemotherapy with or Without Additional Bevacizumab Treatment in HER2-Negative Breast CancerSiri Helene Bertelsen Brandal, Torgeir Mo, Anne Fangberget, et al.
Radiology|March 2, 2018
Digital Breast Tomosynthesis and Synthetic 2D Mammography versus Digital Mammography: Evaluation in a Population-based Screening ProgramSolveig Hofvind, Tone Hovda, Åsne S Holen, et al.
Pageof 1